Athena Countouriotis's Net Worth

Athena Countouriotis's net worth is estimated to be at least $5,959,020.14 as of 05/27/2024. CoreStreet's estimation of Athena Countouriotis's net worth is based on their sale of stock and current holding of stock.

Athena Countouriotis is CEO at Turning Point Therapeutics Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,971 units of TPTX stock on 02/09/2022. Their biggest sale was on 02/09/2021 when they sold 25,666 units of Turning Point Therapeutics Inc stock for $3,559,360.88. They typically trade 1 times per year.

Total value of insider buys:
  • $1,063,360.00
Total value of insider sells:
  • $4,895,660.14
Most recent insider trade:
  • Feb. 9, 2022

Athena Countouriotis's Insider Trading History

Turning Point Therapeutics IncTitleAmountPriceTypeTotal Value
Feb. 9, 2022
CEO2,971$36.30Sell$107,847.30
Feb. 11, 2021
CEO8,942$137.38Sell$1,228,451.96
Feb. 9, 2021
CEO25,666$138.68Sell$3,559,360.88
May 21, 2020
CEO4,166$60.00Buy$249,960.00
Sept. 10, 2019
CEO10,000$45.00Buy$450,000.00
April 22, 2019
CEO12,000$18.00Buy$216,000.00
Passage Bio IncTitleAmountPriceTypeTotal Value
March 24, 2020
Director10,000$14.74Buy$147,400.00